Chief Commercial Officer

Paul Gillespie

Paul is an expert API clinician, specializing in psychedelic & cannabis wellness, working intimately with phytocannabinoids, psychedelics and nootropics delivery methods, be it transdermal, nasal atomizer, meltaway stripes and nano emulsion. He’s created and formulated products for both private and public companies, including: General Hemp, Hemp Meds, Kannaway, Canna-Candys. Paul is instrumental in establishing the wellness platform for precise cannabis dosing, using A.I. He had market research with Luth Research in San Diego that focused on consumer behavior and correlate data with consumer purchases. He innovated nicotine reduction and vape safety.